New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Cognition Therapeutics, Inc.
CGTX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

23M

Biotechnology

Next Earning date - 07 Nov 2024

23M

Biotechnology

Next Earning date - 07 Nov 2024

0.56USD
Shape-0.03 ( -4.24%)
favorite-chart

Relative Strenght

36
favorite-chart

Volume Buzz

-74%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

81%

Quote Panel

Shape
Updated October 27, 2024
1W 19.76 % 1M 20.55 % 3M -57.53 % 1Y -48.17 %

Key Metrics

Shape
  • Market Cap

    22.67M


  • Shares Outstanding

    40.13M


  • Share in Float

    33.80M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    0.5649


  • Average Volume

    1.21M


  • Beta

    1.354


  • Range

    0.34-2.95


  • Industry

    Biotechnology


  • Website

    https://www.cogrx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

60.94x

P/S Ratio

0.98x

P/B Ratio

0.0

Debt/Equity

-8355.4%

Net Margin

$-0.9

EPS

How CGTX compares to sector?

P/E Ratio

Relative Strength

Shape

CGTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$0.78

Shape-331%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

B. Riley

downgrade

Previous: Not converted

2024-08-06

Now: Neutral

Cantor Fitzgerald

downgrade

Previous: Not converted

2024-07-29

Now: Neutral

Chardan Capital

initialise

Previous: Not converted

2024-06-06

Now: Buy

H.C. Wainwright

initialise

Previous: Not converted

2024-05-29

Now: Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.29
vs -8.12

Q4.22

arrow
arrow

N/A

-0.20
vs -0.35

Q1.23

arrow
arrow

N/A

-0.21
vs -0.17

Q2.23

arrow
arrow

N/A

-0.16
vs -0.25

Q3.23

arrow
arrow

N/A

-0.22
vs -0.29

Q4.23

arrow
arrow

N/A

-0.27
vs -0.20

Q1.24

arrow
arrow

N/A

-0.27
vs -0.21

Q2.24

arrow
arrow

N/A

-0.18
vs -0.16

Q3.24

arrow
arrow

N/A

-0.20
vs -0.22

Q4.24

arrow
arrow

N/A

-0.18
vs -0.27

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

372K  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-2%

-0.02
vs -0.13

Q4.22

arrow
arrow

+27%

0.27
vs -0.02

Q1.23

arrow
arrow

-9%

-0.09
vs 0.27

Q2.23

arrow
arrow

-14%

-0.14
vs -0.09

Q3.23

arrow
arrow

-23%

-0.23
vs -0.14

Q4.23

arrow
arrow

-33%

-0.33
vs -0.23

Q1.24

arrow
arrow

-32%

-0.32
vs -0.33

Q2.24

arrow
arrow

-31%

-0.31
vs -0.32

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

29

29
vs 28

4%

Q4.22

arrow
arrow

33

33
vs 29

14%

Q1.23

arrow
arrow

31

31
vs 33

-6%

Q2.23

arrow
arrow

33

33
vs 31

6%

Q3.23

arrow
arrow

34

34
vs 33

3%

Q4.23

arrow
arrow

36

36
vs 34

6%

Q1.24

arrow
arrow

46

46
vs 36

28%

Q2.24

arrow
arrow

46

46
vs 46

NA

Earnings Growth

Latest News